Home
Storia in 3 fonti
AstraZeneca pauses £200m Cambridge expansion amid NHS pricing row
Drug companies increasingly frustrated with the Government over surging NHS clawbacks
- ·
telegraph.co.uk
US drugmaker scraps plans for £1bn UK research centre
Merck criticises ‘successive UK governments’ as it cancels King’s Cross development
- ·
AstraZeneca pauses £200m Cambridge expansion amid NHS pricing row
Drug companies increasingly frustrated with the Government over surging NHS clawbacks
- ·
bbc.com
AstraZeneca pauses £200m Cambridge investment
Its decision comes as the industry says there is a lack of government investment and as the US pressures firms to invest there.
- ·
cnbc.com
AstraZeneca pauses $270 million investment in Britain
AstraZeneca has paused a planned investment in the U.K., which had been set to create 1,000 jobs.